Stockscreener 앱 받기
0.472
3.79%
-0.0186
Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스
Lipella Pharmaceuticals Inc (LIPO) Becoming More Attractive for Investors - Knox Daily
Insider Buying: Kaufman Jonathan H, Lipella Pharmaceuticals Inc [LIPO] insider invested 10,000 shares - Knox Daily
The time has not yet come to remove your chips from the table: Lipella Pharmaceuticals Inc (LIPO) - SETE News
Lipella Pharmaceuticals Inc Inc. (LIPO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month - Morningstar
Lipella reports positive phase 2a trial results for OLP treatment - Investing.com
Lipella Pharmaceuticals Reports Encouraging Early - GlobeNewswire
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus - StockTitan
A year in review: Lipella Pharmaceuticals Inc (LIPO)’s performance in the last year - US Post News
Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex
Lipella stock soars 200% on Phase 2 study initiation - MSN
Matthew E Korenberg At Ligand Pharmaceuticals Executes Options Exercise, Realizing $260K - Benzinga
Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - Defense World
John Deneen Collins Sells 85,126 Shares of LivePerson, Inc. (NASDAQ:LPSN) Stock - Defense World
Lepidico Wins Crucial Road Access Dispute - TipRanks
Louisiana-Pacific director sells $245,750 in company stock By Investing.com - Investing.com Canada
LivePerson CFO and COO sells over $89k in company stock - Investing.com
Pliant Therapeutics (NASDAQ:PLRX) Sees Large Volume Increase - MarketBeat
A stock that deserves closer examination: Lipella Pharmaceuticals Inc (LIPO) - US Post News
Moody’s to withdraw Lippo Malls Indonesia Retail Trust’s credit ratings - The Edge Singapore
UK Government gets behind Lepidico’s process technologies - Mining.com.au
Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $12.00 - MarketBeat
Understanding the Risks of Investing in Lipella Pharmaceuticals Inc (LIPO) - Knox Daily
Stock Surge: Lipella Pharmaceuticals Inc (LIPO) Closes at 0.40, Marking a 6.96 Increase/Decrease - The Dwinnex
A closer look at LIPO’s price-to-free cash flow ratio - US Post News
Interstitial Cystitis Market Growth Anticipated by 2032 | Companies includes Merck, Teva Pharmaceutical, Lipella Pharmaceuticals, Seikagaku Corporation - Barchart
Lipella Pharmaceuticals announces board election and reverse stock split - Investing.com
Lipella Pharmaceuticals Inc [LIPO] Investment Guide: What You Need to Know - Knox Daily
Lipella Pharmaceuticals stock more than doubles in 3 days as FDA approves IND for OLP treatment - MSN
A Guide To The Risks Of Investing In Lipella Pharmaceuticals Inc (LIPO) - Knox Daily
LIPO’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
LIPOLipella Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan
Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York - GlobeNewswire
Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York - StockTitan
Investing in Lipella Pharmaceuticals Inc (LIPO): What You Must Know - Knox Daily
Lipella Pharmaceuticals Inc (LIPO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com
Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
Lipella Pharmaceuticals Inc [LIPO] moved up 1.71: Why It’s Important - The DBT News
Ratio Revelations: Lipella Pharmaceuticals Inc (LIPO)’s Financial Metrics in the Spotlight - The Dwinnex
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research - GlobeNewswire
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research - StockTitan
Lipella Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Lipella Pharmaceuticals Inc (LIPO) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference - GlobeNewswire
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference - StockTitan
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference - Yahoo Finance
Financial Review: Lipella Pharmaceuticals (NASDAQ:LIPO) vs. Sagimet Biosciences (NASDAQ:SGMT) - Defense World
Lipella Pharmaceuticals Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.27 loss in 2Q 2023) - Simply Wall St
Lipella Pharmaceuticals Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.27 loss in 2Q 2023) - Yahoo Finance
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q2 2024 - InvestorPlace
Short Interest in Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) Expands By 27,928.1% - Defense World
Lipella Pharmaceuticals begins phase 2a trial for oral lichen planus By Investing.com - Investing.com Australia
Lipella doses first two subjects in Phase IIa oral lichen planus treatment trial - Yahoo Finance
Lipella Pharmaceuticals begins phase 2a trial for oral lichen planus - Investing.com
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial - GlobeNewswire
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial - StockTitan
Interstitial Cystitis Clinical Trial Insights 2024: - openPR
Lipella Pharmaceuticals sets annual meeting date, updates proposal deadline - Investing.com
Taking a look at what insiders are doing to gauge the Lipella Pharmaceuticals Inc (LIPO)’s direction - Knox Daily
Lipella Pharmaceuticals Announces Closing of $1.28 Million - GlobeNewswire
Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
Lipella Pharmaceuticals announces $1.28 million stock offering By Investing.com - Investing.com Australia
Lipella Pharmaceuticals announces $1.28 million stock offering - Investing.com India
Form 424B5 LIPELLA PHARMACEUTICALS - StreetInsider.com
SEC Form 424B5 filed by Lipella Pharmaceuticals Inc. - Quantisnow
Lipella Pharmaceuticals announces $1.28 million stock offering - Investing.com
0.05%
4.86%
자본화:
|
볼륨(24시간):